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SUMMARY – Contact skin lesions may be the consequences of contact with various irritants or 
allergens, or due to other factors (e.g., UV radiation, microbials), intrinsic factors (e.g., in autoimmune 
responses), or even their combination. Th ere are many substances related to irritant contact dermatitis 
(CD), causing irritant or toxic eff ects, e.g., chemical and physical agents, plants, phototoxic agents, 
airborne irritants, etc. Impaired barrier function (e.g., aberrancies in epidermal pH buff ering capabili-
ties) also participates by promoting bacterial biofi lms and creating an environment favoring sensitiza-
tion. Development of allergic CD skin lesions includes complex immune pathways and infl ammatory 
mediators, infl uenced by both genetic (predominantly fi laggrin mutations) and environmental trig-
gers. In the pathogenesis of allergic CD, antimicrobial peptides play a prominent role; they are pro-
duced by various skin cells (e.g., keratinocytes, sebocytes) and move to infl amed lesions during an 
infl ammation process. Also, in allergic CD skin lesions, the skin shows diff erent types of immune 
 responses to individual allergens, although clinical manifestations do not depend on the causative 
 allergen type, e.g., nickel stimulates immune activation primarily of the Th 1/Th 17 and Th 22 compo-
nents. Also important are alarmins, proteases, immunoproteomes, lipids, natural moisturizing factors, 
tight junctions, smoking, etc. We expect that future perspectives may reveal new pathogenetic factors 
and scientifi c data important for the workup and treatment of patients with CD.
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Introduction
Contact dermatitis (CD) is an infl ammatory skin 
disease caused by chemicals or metal ions that exert 
irritant (toxic) eff ects, or by small reactive chemicals 
(contact allergens) that modify proteins and induce 
immune responses (predominantly by T-cell re-
sponse)1. Consequently, CD may manifest as irritant 
CD and allergic CD, which may occur in acute or 
chronic forms.
Irritant CD is a nonspecifi c skin response to direct 
chemical skin damage and/with releasing infl amma-
tory mediators, while allergic CD is a delayed hyper-
sensitivity reaction (type IV) to allergens, which in-
cludes immune responses (due to the interaction of T 
cells and cytokines)1. In diff erentiating the two dis-
eases, it is pointed out that in irritant CD there are no 
immune reactions; no prior exposure to any substance 
(sensitization) is required; and most individuals ex-
posed to such (usually aggressive) substance manifest a 
similar reaction2. Th ereby, contact skin lesions may be 
the consequences of contact with various irritants or 
allergens, or due to other factors (e.g., UV radiation, 
microbials), intrinsic factors (not always well-defi ned 
stimuli, e.g., in autoimmune responses), or even their 
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combination3-11. When the occurrence of irritant CD 
and allergic CD is related to work activities, possible 
occupational CD may occur, related to diff erent work-
place factors (e.g., alcohol-based disinfectants and de-
tergents, latex gloves)6,9,11.
Irritant CD and allergic CD are relatively frequent 
dermatoses. Irritant CD is more common than allergic 
CD. Although the incidence and prevalence of allergic 
CD in the general population are not precisely esti-
mated, the prevalence of allergic CD is considered to 
be 15% to 25%1.
Th e Pathomechanisms of Contact Dermatitis
When irritant CD lesions occur after exposure to a 
substance (even in small concentrations), eff ects may 
accumulate due to repeated infl uence commonly lead-
ing to chronic skin damages and skin lesions. Irritant 
CD may manifest in a form of acute and chronic le-
sions. Th ere are many substances related to irritant 
CD, caused by their irritant or toxic eff ects, e.g., chem-
ical agents, physical agents, plants, phototoxic agents, 
airborne irritants, etc.1,2. Th us, skin lesions may be 
caused by diff erent chemical agents (alkaline and acid 
solutions, organic solvents, tensides, croton oil), physi-
cal agents (UV radiation, x-rays, other ionizing radia-
tion, laser rays, heat, cold and mechanical factors), food 
stuff s (e.g., asparagus, mustard, fruit juices), plants 
(e.g., agave, anemones, many others) and chemical 
warfare agents4-11. Contact skin lesions due to photo-
toxic agents are also possible. An irritating impact of 
the environment resulting from airborne irritants may 
also occur; irritating dusts or fumes can damage un-
covered skin (especially the face), causing edema and 
blisters.
Chronic irritant CD may be induced by any sub-
stance causing acute irritant CD that, when in small 
concentrations, can accumulate eff ects causing chronic 
skin damages (even water, in cases of frequent hand 
washing, working in water, taking shower, bathing, 
etc.)2. Consequently, it gradually changes, damaging 
and eliminating the skin protective barriers, particu-
larly the protective lipid fi lm on the surface of the 
horny layer, the appertaining acid pH of that layer and 
the very horny layer itself12-14.
On the other hand, in allergic CD, skin lesions are 
induced by immune reactions and by sensitization to 
some substance (allergen) mediated by T cells, occur-
ring through the sensitization (aff erent) phase and the 
elicitation (eff erent) phase. Th e results of patch test, 
used for checking and proving the delayed hypersensi-
tivity reaction (type IV) are the most important diag-
nostic indicators in diff erentiation between irritant 
and allergic CD2. Various substances can be allergens, 
particularly metal salts which interact weakly with 
skin proteins and thus form complexes. At the fi rst 
epicutaneous contact (the sensitization phase), the 
haptens stimulate keratinocyt es to express adhesion 
molecules (ICAM-1), proinfl ammatory cytokines 
(IL-1-, IL-1, TNF-, IL-6) and chemokines (IP-
10, MCP-1, RANTES, CCL18)15-18. Th e epidermal 
Langerhans cells then take over and ingest the neoan-
tigen, process it, express MHC class I and II mole-
cules, and migrate to the regional lymph nodes where 
they present the antigen to naïve T cells2.
It turned out that, in allergic CD, keratinocytes se-
crete proinfl ammatory cytokines and chemokines that 
activate epidermal Langerhans cells and dermal vascu-
lar endothelial cells, which also express adhesion mol-
ecules and enable extravasation of the sensitized T 
cells (CD8, Tr1), mastocytes, basophils and immuno-
cytes19,20. During the next contact with the same hap-
ten, in the dermis, the antigen-presenting cells (APCs) 
present the neoantigen to the memory CD8+ lympho-
cytes, which develop the eff ector cytotoxic T lympho-
cyte (CTL) function. Th ey bind with the keratino-
cytes expressing pMHC I and secreting interferon- 
(IFN-). Th e IFN- (secreted from the CTLs and 
from the activated macrophages) stimulates the ex-
pression of Fas molecules on keratinocytes and this 
(IFN-), in turn, binds the FasL expressed by the 
CTLs, which leads to apoptosis. In the fi nal phase, 
IFN- stimulates mastocytes and basophils to release 
lytic mediators; it also stimulates vasodilators (e.g., 
histamine) and chemokines to enable further infi ltra-
tion of cells and amplifi cation of an infl ammatory re-
sponse19,20. Within days, the macrophages migrate to 
the lymph nodes, where they express co-stimulatory 
molecules (CD80/86), present the antigen/allergen to 
the lymphocytes expressing late integrins [very late 
antigen (VLA)], ‘homing’ receptors (CD44), while 
also presenting the third infi ltration wave and trigger-
ing an adaptive immune response1,2,21.
Th us, development of allergic CD skin lesions in-
cludes complex immune pathways, infl uenced by both 
genetic and environmental triggers14. Th ere are promi-
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nent roles of genetic variations and mutations (pre-
dominantly fi laggrin mutations) and impaired barrier 
function (e.g., aberrancies in epidermal pH buff ering 
capabilities), which may promote bacterial biofi lms 
and create an environment favoring sensitization13,22,23. 
Regarding genetics, according to research data, fi lag-
grin mutations (R501X, 2282del4, and R2447X) were 
identifi ed in 16.9% of patients with hand eczema and 
were signifi cantly associated with skin lesions (skin fi s-
sures on the fi ngers and heels).
Besides individual’s predisposition, in infl ammato-
ry skin diseases the lesion development process and 
involved factors (including cytokines and immune 
cells) depend on the trigger3. Also important are anti-
microbial peptides and alarmins, skin tight junctions, 
natural moisturizing factors, immunoproteomes, pro-
teases, lipids, smoking, etc.24,25.
For allergic CD also important is how the allergens 
pass through the cell membrane channels, depending 
on allergen type. For example, in the skin lesions oc-
curring due to nickel allergy, the water-permeable 
nickel salts can pass through the cell membrane chan-
nels by using ion exchange and, together with other 
molecules (e.g., proteins, amino acids), be incorporated 
in the cell. It has also been observed that in an immune 
response to nickel allergy, Th 1 cells are more dominant 
than Th 2 cells26.
Of the other factors involved in the pathogenesis of 
allergic CD, there is the role of antimicrobial peptides 
(AMPs) produced by various skin cells (e.g., keratino-
cytes, sebocytes) moving to the infl amed lesion area 
during an infl ammation process. As the AMPs act as 
protective antimicrobial barrier protecting the skin 
from bacterial and viral infections, they are called 
alarmins (because of their ‘alarming’ function and par-
ticipation in inherent and acquired immune respons-
es)24,27. Also, the AMP expression is regulated with the 
microbial factor and infl ammatory cytokines. Some 
AMPs are generated if needed [as human -defensin 
(HBD) HBD-1 and HBD 2 as cathelicidin]27.
It has been confi rmed that in infl amed CD lesions, 
skin tight junction proteins are often aff ected3. Th us, 
impaired barrier function is related to tight junctions, 
which form a barrier in the epidermal granular cell 
layer and are involved in keratinocyte proliferation, 
diff erentiation, cell-cell adhesion, and apoptosis.
It is also important that in irritant CD, occlusion 
decreases the skin barrier function and signifi cantly 
enhances the irritant-induced barrier damaging ef-
fects. Also, according to research data, in irritant-ex-
posed fi elds the natural moisturizing factor values were 
signifi cantly decreased compared to non-exposed 
fi elds, indicating that occlusion enhanced decrease in 
the natural moisturizing factor12.
Also, CD is characterized by barrier disruption and 
infl ammation, similar to atopic dermatitis (AD) and 
psoriasis, with unique epidermal signatures and com-
mon infl ammatory pathways identifi ed by transcrip-
tomic profi ling28. Proteomic profi ling in subjects with 
both CD and AD identifi ed additional dysregulated 
proteins (compared to subjects with either condition 
alone), indicating an exacerbated infl ammation reac-
tion. Unique serum proteomic signatures have been 
identifi ed that may distinguish between infl ammatory 
skin diseases (CD, AD) despite similar epidermal bar-
rier disruption and epithelial infl ammation28.
Clinical Manifestations of Contact Dermatitis
Clinically, irritant CD can occur as an acute or 
chronic disease. Lesions may occur anywhere but com-
monly appear on the hands2. Acute irritant CD is typ-
ically characterized by erythema, blisters, pustules, 
hemorrhage, crusts, scales and erosions, and also with 
pruritus or even pain (Fig. 1). Skin lesions in acute ir-
ritant CD are predominantly sharply bordered in the 
areas of contact (distant spread does not occur) and 
usually asymmetric.
On the other hand, chronic irritant CD is charac-
terized by diff use or localized lesions with typically 
poorly defi ned erythematous scaly patches and plaques, 
dryness of skin, lichenifi cation and desquamation2. Ir-
ritant skin lesions commonly occur on the back of the 
hands and forearms (palms have greater intrinsic resis-
tance). Th e disease is often asymmetric, with the dom-
inant hand more aff ected. As the disease persists, li-
chenifi cation and fi ssures develop, with possible nail 
damage (paronychia with nail dystrophy, pitting, oil 
spots, etc.). Distant reactions usually do not occur and 
the disease is usually limited to the areas of repeated 
contact.
In allergic CD skin lesions, there are several diff er-
ent clinical phases, i.e. erythematous phase with an 
unsharply delineated erythema or skin edema; and 
madidans phase characterized by erosions and moist-
ening (Fig. 2). In the next stage, crusts appear, followed 
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by the fi nal, squamous stage, when the horny layer re-
pairs itself. Acute allergic CD develops after 24-48 
hours. Skin lesions are initially asymmetric and limited 
to the area of contact, but often spread/disseminate 
later. In the case of severe reactions, there is swelling 
and blistering. Of the general symptoms in allergic 
CD, itching is very noticeable. Th e major clinical dif-
ferences between irritant CD and allergic CD are the 
more rapid onset of irritant CD and the tendency of 
allergic CD to spread. It is typical that the widespread 
reaction is usually symmetric, although the primary 
reaction is not.
When skin lesions of allergic CD persist, chronic 
allergic CD can develop (Fig. 3). Skin lesions may 
Fig. 5. Histology of irritant contact dermatitis skin lesion: 
acanthotic epidermis, spongiosis, spongiotic bubbles with 
exocytosis of lymphocytes into the spongiotic epidermis. 
In the subepidermal dermis, swollen capillaries and 
perivascular lymphocytic infi ltrates are seen (H&E, X400).
Fig. 1. Acute irritant contact dermatitis 
with impetiginization.
Fig. 2. Acute allergic contact dermatitis.
Fig. 3. Chronic irritant contact dermatitis.
Fig. 4. Histology of irritant contact dermatitis skin lesion 
(punch biopsy, H&E, X100).
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creep up subtly with no acute phase or appear on top 
of chronic irritant CD. Typical features include a sym-
metric pattern, less sharp borders, and distant spread. 
Also, distant lesions may occur, which are typically 
papulovesicular. Th e main feature of chronic allergic 
CD is epidermal reaction with lichenifi cation, fi ssures, 
and pruritus2.
Histologic Analysis 
of Contact Dermatitis Lesions
Histologic analysis of biopsy specimens of skin le-
sions in irritant CD and allergic CD shows nonspe-
cifi c pictures, usually including spongiosis, spongiotic 
bubbles, numerous neutrophils in the epidermis, swol-
len capillaries in the subepidermal dermis, and peri-
vascular lymphocytic infi ltrates29 (Figs. 4 and 5). His-
topathology of acute irritant CD reveals spongiosis 
and vesicles or blisters in the epidermis, or sometimes 
epidermal necrosis or even no epidermis. In the der-
mis, there is a perivascular infi ltrate with exocytosis of 
neutrophils and lymphocytes, along with vasodilata-
tion and edema. Generally, in the cases when epider-
mal damage predominates, it indicates toxic damage2. 
However, histopathology of chronic irritant CD of the 
hand does not show histologic clues to the etiology of 
chronic irritant CD. Uncommon fi nding are acute 
changes (such as spongiosis and edema), while expect-
ed fi nding are reactive epidermal changes (such as li-
chenifi cation), along with a dermal perivascular lym-
phohistiocytic infi ltrate.
Histopathology of allergic CD shows lymphocytic 
perivascular infi ltrate, high dermal edema, and epider-
mal spongiosis and exocytosis in the dermis2. When 
lesions persist in chronic allergic CD, the epidermis 
shows reactive change (acanthosis, hyperkeratosis, 
parakeratosis) with little spongiosis and dermal mixed 
infl ammatory infi ltrate.
Histologic fi nding of irritant CD lesions shows 
moderate spongiosis, intracellular edema, exocytosis, 
progression of infl ammatory infi ltrate into the epider-
mis, and a reduced number of CD4+ Langerhans cells 
in the epidermis. Similarly, the following can be found 
in allergic CD lesions: spongiosis with predominating 
microvesicles, focal distribution of infl ammatory infi l-
trate in the epidermis and sparse pustulation, and re-
duced numbers of CD4+ Langerhans cells that grow 
with time. In comparison, irritant CD lesions histo-
logically commonly present with mild spongiosis, epi-
dermal cell necrosis, epidermal neutrophilic infi ltra-
tion, whereas in allergic CD dermal infl ammatory in-
fi ltrates are predominated with lymphocytes and other 
mononuclear cells1.
Immunohistochemistry 
of Contact Dermatitis Skin Lesions
Immunohistochemical analyses are a useful re-
search method because they enable localization of spe-
cifi c active antigens by use of targeted antibodies, thus 
providing additional information on individual dis-
eases, including CD. In addition to diagnostic pur-
poses, immunohistochemistry is also used in scientifi c 
research, helping us gain a better insight into the dis-
tribution and localization of biomarkers and expres-
sions of individual proteins in various tissues30-32.
In both irritant CD and allergic CD, immunohis-
tochemistry of skin lesions shows infi ltration of pre-
dominantly CD4+ T cells and some CD8+T cells. In 
their acute phase, there is an increased expression of 
IL-2, ICAM-1 and HLA-DR on keratinocytes33.
In irritant CD lesions, a decrease in the number of 
CD4+ Langerhans cells can be seen. As for allergic 
CD, the number of CD4+ Langerhans cells is reduced 
in the beginning, but it later increases. In irritant CD 
and allergic CD, the cytokines [primarily interleukins 
(ILs)] also have an important role in the infl ammatory 
processes. Although the types of cytokines involved in 
irritant CD are somewhat diff erent from those in al-
lergic CD, some cytokines are important for both 
types of CD. For instance, IL-2 and IFN- (generated 
by irritation of damaged keratinocytes) participate in 
the migration and activation of infl ammatory cells and 
initiating infl ammatory responses, thus participating 
in both CD types34. Th ere are minor diff erences too; 
staining for IL-1 receptor antagonist is more expressed 
in allergic CD (in the dermis in a later stage), whereas 
IFN- is more expressed in infl ammatory responses in 
irritant CD35.
Analysis of skin biopsies in allergic CD (poly-
merase chain reaction and immunohistochemistry) in 
patients with positive patch test established higher 
levels of the IFN-, IL-4, IL-17A, IL-9 and PU.1 cy-
tokines in comparison with normal skin. Immunohis-
tochemically, PU.1+, CD3+, PU.1+ and CD4+ cells 
Gaby Novak-Bilić et al. Irritant and allergic contact dermatitis
718 Acta Clin Croat, Vol. 57, No. 4, 2018
were identifi ed in biopsies of patients with allergic 
CD. As regards allergic CD, it was also established 
that IL-9 had a direct eff ect on Th 1 lymphocytes, as 
well as on stimulation of IL-4 secretion, the regulatory 
role of which is important for Th 1 lymphocytes36.
Th us, immune response in CD is complex and in-
volves diff erent cells1,2,15,24. Some studies have shown 
that, in allergic CD, determining mRNA expressions 
for IL-1 has a major role in the induction phase of 
the disease, as it increases the expression of MHC II 
molecules on Langerhans cells and induces molecu-
lar adhesion [through intercellular adhesion mole-
cule-1 (ICAM-1), vascular cell adhesion molecule-1 
(VCAM-1), endothelial leukocyte adhesion mole-
cule-1 (ELAM-1), and lymphocyte function anti-
gen-3 (LFA-3)]15.
More recent studies have reported evidence that in 
allergic CD skin lesions, skin shows diff erent types of 
reactions and diff erent immune responses to individu-
al allergens37. Although clinical manifestations do not 
depend on the causative allergen type, skin lesions 
show a marked immune process/polarization depend-
ing on the allergen. Th us, nickel stimulates immune 
activation primarily of the Th 1/Th 17 and Th 22 com-
ponents.
A recent research supports the participation of NK 
cells in skin lesions26. Some animal studies emphasize 
the role of NK cells (also called iNK T cells and 
Va14iNK T cells), which are the T cells that express 
receptors for CD161c. Th us, NK T cells recognize the 
glycolipids presented in the context of CD1d (MHC 
class I-similar molecules) and, upon activation, the 
Th 1 and Th 2 molecules are produced, as well as IFN- 
and IL-4 that regulate the immune response in skin 
lesions26,38.
Conclusion
However, although irritant and allergic CD have 
been studied for numerous biomarkers and factors (ge-
netics, infl ammatory mediators, antimicrobial peptides 
and alarmins, skin tight junctions, natural moisturiz-
ing factors, smoking, etc.), convincing, specifi c indica-
tors and biomarkers have not yet been confi rmed. We 
expect that future perspectives may reveal new patho-
genetic factors and scientifi c data important for the 
workup and treatment of patients with CD.
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Sažetak
IRITATIVNI I ALERGIJSKI KONTAKTNI DERMATITIS – OBILJEŽJA LEZIJA KOŽE
G. Novak-Bilić, M. Vučić, I. Japundžić, J. Meštrović-Štefekov, S. Stanić-Duktaj i L. Lugović-Mihić
Kontaktne reakcije kože mogu biti posljedice kontakta s različitim iritansima ili alergenima ili mogu nastati zbog drugih 
čimbenika (npr. UV zračenja, mikroorganizama), unutarnjih čimbenika (npr. kod autoimunih reakcija) ili njihovom kombi-
nacijom. Postoje mnoge tvari koje su povezane s pojavom iritativnog kontaktnog dermatitisa (KD) te uzrokuju iritativne ili 
toksične učinke: kemijske i fi zikalne tvari, biljke, fototoksične tvari, okolišni čimbenici itd. Također oštećena funkcija kožne 
barijere (npr. odstupanja u epidermalnim pH puferskim sposobnostima) sudjeluje u tome promicanjem bakterijskih biofi l-
mova i stvaranjem okruženja koja pogoduju senzibilizaciji. Razvoj kožnih oštećenja kod alergijskog KD-a obuhvaća kom-
pleksne imunosne puteve i upalne medijatore koji su pod utjecajem i genetskih čimbenika (pretežno mutacija fi lagrina) i 
okidača iz okoliša. U patogenezi alergijskog KD-a istaknuta je uloga antimikrobnih peptida koji nastaju kao proizvod razli-
čitih kožnih stanica (npr. keratinociti, sebociti) i potom prelaze u kožne lezije tijekom procesa upale. Također, kod kožnih 
lezija u alergijskom KD-u koža pokazuje različite tipove imunosnih odgovora na pojedine alergene, iako kliničke manifesta-
cije ne ovise o vrsti uzročnog alergena; npr. nikal stimulira imunosnu aktivaciju prvenstveno Th 1/Th 17 i Th 22 komponenata. 
Također su važni alarmini, proteaze, imunoproteomi, lipidi, prirodni hidratantni čimbenici, međustanične veze, pušenje itd. 
Očekujemo da će se istraživanjima u budućnosti otkriti novi patogenetski čimbenici i znanstvene spoznaje važne za rad i 
 liječenje bolesnika s KD-om.
Ključne riječi: Dermatitis, alergijski kontaktni; Dermatitis, iritativni; Upala kože; Etiopatogeneza; Imunohistokemija; Histo-
logija; Čimbenici
